Baxter International, Inc. (BAX)

17.26 +0.28 (+1.65%) USD  |  NYSE  |  May 07, 10:39
More

Baxter International SG&A Expense (TTM) : 2.915B for March 31, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for BAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Becton, Dickinson & Co. 5.352B
ResMed, Inc. 1.083B
Abbott Laboratories 13.01B
Boston Scientific Corp. 7.072B
West Pharmaceutical Services, Inc. 405.10M